Aveanna Healthcare (AVAH) Q2 2026 Earnings Call Transcript
Aveanna Healthcare (AVAH) reported Q2 2026 revenue of $670.5M, up 13.7% YoY, with adjusted EBITDA of $95.4M, up 8%. All segments grew, with Private Duty Services leading at $553.9M, up 14%. The company raised full-year revenue guidance to over $2.68B and adjusted EBITDA to over $365M. Management highlighted strategic payer alignments, acquisitions, and cost efficiencies.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise expectations for earnings per share and cash flow, likely supporting a bullish stance.
Market read
First disclosure of Q2 results and upgraded guidance provides fresh material for traders; likely to move AVAH stock.
What to watch
Potential headwinds from labor market tightening and future regulatory changes in Medicaid reimbursement.
Background
Aveanna Healthcare Holdings (AVAH) reported its Q2 2026 earnings, highlighting revenue growth across all segments and raising full‑year guidance.
Ticker impact
Q2 2026 earnings released with revenue $670.5M (+13.7% YoY) and raised full-year guidance above $2.68B.
Potential price appreciation on the back of better-than-expected results and higher guidance.
Revenue beat expectations, margins expanding, and guidance raised, all new information for investors.
Market effects
Home health and hospice sector may see renewed investor interest as Aveanna raises growth outlook.
California rate increase could benefit other home‑health providers operating in the state.
Limited; impact primarily on U.S. healthcare services sector.
Counterpoint
Higher guidance may already be priced in; watch for execution risk on integration of recent acquisitions.
Key entities
- ExecutiveJeffrey Shaner
CEO of Aveanna Healthcare, discussed growth outlook and upcoming California rate increase.
- ExecutiveMatthew Buckhalter
CFO, noted interest expense reduction and debt hedging.
